These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3658557)

  • 1. The clinical pharmacology of vancomycin in seriously ill preterm infants.
    Reed MD; Kliegman RM; Weiner JS; Huang M; Yamashita TS; Blumer JL
    Pediatr Res; 1987 Sep; 22(3):360-3. PubMed ID: 3658557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
    Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin pharmacokinetics in premature infants.
    Gross JR; Kaplan SL; Kramer WG; Mason EO
    Pediatr Pharmacol (New York); 1985; 5(1):17-22. PubMed ID: 3991250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
    Reiter PD; Doron MW
    J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O; Cambonie G; Barbotte E; Meyer P; Devine C; Milesi C; Pidoux O; Badr M; Picaud JC
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F418-21. PubMed ID: 18450803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of vancomycin in neonates of postconceptional age less than or equal to 32 weeks].
    Ginovart Galiana G; Mangues Bafalluy MA; Demestre Guasch X; Farré Riba R; Lopes Santos AP; Altirriba Valls O
    An Esp Pediatr; 1996 Aug; 45(2):167-71. PubMed ID: 8967647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of bumetanide in critically ill infants.
    Sullivan JE; Witte MK; Yamashita TS; Myers CM; Blumer JL
    Clin Pharmacol Ther; 1996 Oct; 60(4):405-13. PubMed ID: 8873688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and multiple-dose pharmacokinetics of intravenously administered vancomycin in dogs.
    Zaghlol HA; Brown SA
    Am J Vet Res; 1988 Sep; 49(9):1637-40. PubMed ID: 3223677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing in neonatal patients: the controversy continues.
    Wandstrat TL; Phleps SJ
    Neonatal Netw; 1994 Apr; 13(3):33-9. PubMed ID: 8152409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin pharmacokinetics in very low birth weight neonates.
    Leonard MB; Koren G; Stevenson DK; Prober CG
    Pediatr Infect Dis J; 1989 May; 8(5):282-6. PubMed ID: 2657617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants.
    Lisby-Sutch SM; Nahata MC
    Eur J Clin Pharmacol; 1988; 35(6):637-42. PubMed ID: 3234472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin pharmacokinetics in infants: relationships to indices of maturation.
    Schaible DH; Rocci ML; Alpert GA; Campos JM; Paul MH; Polin RA; Plotkin SA
    Pediatr Infect Dis; 1986; 5(3):304-8. PubMed ID: 3725640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin pharmacokinetics in small, seriously ill infants.
    Naqvi SH; Keenan WJ; Reichley RM; Fortune KP
    Am J Dis Child; 1986 Feb; 140(2):107-10. PubMed ID: 3946318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vancomycin in patients with severely impaired renal function.
    Gonzalez-Martin G; Acuna V; Perez C; Labarca J; Guevara A; Tagle R
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):71-5. PubMed ID: 8929749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.